Molecular targets for neuroprotection

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 5, Issue SUPPL. 1, 2004, Pages 14-18

  Przedborski, Serge ^a  

^a Howard Hughes Medical Institute   (United States)

Author keywords

Amyotrophic lateral sclerosis; Apoptosis; Neuroprotection

Indexed keywords

CASPASE; CASPASE 12; CASPASE 2; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CEP 1347; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; FAS ANTIGEN; FAS LIGAND; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1BETA CONVERTING ENZYME; MUTANT PROTEIN; NEW DRUG; PROSTAGLANDIN E2; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEINASE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG TARGETING; EXPERIMENTAL MODEL; FAMILIAL DISEASE; FATALITY; HUMAN; MEDICAL INFORMATION; MEDICAL RESEARCH; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PARALYSIS; PATHOGENESIS; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; RODENT; SPINAL CORD MOTONEURON; TRANSGENIC ANIMAL; TREATMENT PLANNING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; APOPTOSIS; CASPASES; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; NEUROPROTECTIVE AGENTS; PEPTIDE HYDROLASES; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPEROXIDE DISMUTASE;

EID: 6444243845     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/1734470410019780     Document Type: Article

References (22)

1. Shibata N. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology 2001; 21(1): 82-92.
2. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344(22): 1688-1700.
3. Hirano A. Cytopathology of amyotrophic lateral sclerosis. Adv Neurol 1991; 56: 91-101.
4. Przedborski S, Mitsumoto H, Rowland LP. Recent advances in amyotrophic lateral sclerosis research. Curr Neurol Neurosci Rep 2003; 3(1): 70-77.
5. Przedborski S, Vila M, Jackson-Lewis V. Series Introduction: Neurodegeneration: what is it and where are we? J Clin Invest 2003; 111(1): 3-10.
6. Brown RH Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995; 80: 687-692.
7. Guégan C, Przedborski S. Programmed cell death in amyotrophic lateral sclerosis. J Clin Invest 2003; 111(2): 153-161.
8. Vila M, Przedborski S. Neurological diseases: targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci 2003; 4(5): 365-375.
9. McGeer PL, McGeer EG. Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Dis Assoc Disord 1998; 12 (Suppl 2): S1-6.
10. McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 2002; 26(4): 459-470.
11. Hall ED, Oostveen JA, Gurney ME. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 1998; 23(3): 249-256.
12. Almer G, Vukosavic S, Romero N, Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999; 72: 2415-2425.
13. Levine JB, Kong J, Nadler M, Xu Z. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia 1999; 28(3): 215-224.
14. Almer G, Guégan C, Teismann P et al. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 2001; 49(2): 176-185.
15. Drachman DB, Frank K, Dykes-Hoberg M et al. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2002; 52(6): 771-778.
16. Nguyen MD, Julien JP, Rivest S. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann Neurol 2001; 50(5): 630-639.
17. Raoul C, Estevez A, Nishimune H et al. Motor neuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-Linked SOD1 mutations. Neuron 2002; 35(6): 1067-1083.
18. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13(15): 1899-1911.
19. Merry DE, Korsmeyer SJ. Bcl-2 gene family in the nervous system. Annu Rev Neurosci 1997; 20: 245-267.
20. Vukosavic S, Dubois-Dauphin M, Romero N, Przedborski S. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999; 73(6): 2460-2468.
21. Kostic V, Jackson-Lewis V, De Bilbao F, Dubois-Dauphin M, Przedborski S. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 1997; 277(5325): 559-562.
22. Li M, Ona VO, Guégan C et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 2000; 288(5464): 335-339.